Glen Santangelo
Stock Analyst at Jefferies
(2.30)
# 2,530
Out of 4,751 analysts
78
Total ratings
45.83%
Success rate
-1.23%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Buy | $51 | $42.45 | +20.14% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $3.76 | +59.57% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $19.86 | +10.78% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $17.15 | +16.62% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $25.38 | -29.08% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $22.88 | +4.90% | 4 | Sep 19, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $10 | $9.50 | +5.26% | 6 | Sep 17, 2024 | |
| VTRS Viatris | Reinstates: Buy | $15 | $9.53 | +57.40% | 3 | Jul 19, 2024 | |
| HIMS Hims & Hers Health | Maintains: Hold | $14 → $23 | $41.34 | -44.36% | 4 | Jun 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Buy | $19 → $23 | $16.32 | +40.93% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $28.42 | +54.82% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.92 | +55.68% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $164.98 | +39.41% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.59 | +1,594.63% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $31.49 | +122.29% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $14 | $6.96 | +101.15% | 2 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $5.5 | $0.58 | +848.44% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.76 | +177.78% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $3.24 | +332.10% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $75 | $5.62 | +1,234.52% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $69.45 | -33.77% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $80 | $107.00 | -25.23% | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $4.39 | +537.81% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $27.05 | +158.78% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $10.01 | +1,098.80% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.75 | -27.27% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.98 | +843.78% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $4.92 | +631.71% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $64.48 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $620.85 | -72.78% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $31.15 | - | 2 | Jan 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $127.47 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $72.12 | +13.70% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $185.77 | +34.58% | 1 | Dec 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $78 | $11.23 | +594.57% | 1 | Dec 4, 2017 |
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $42.45
Upside: +20.14%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $3.76
Upside: +59.57%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $19.86
Upside: +10.78%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $17.15
Upside: +16.62%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $25.38
Upside: -29.08%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $22.88
Upside: +4.90%
Teladoc Health
Sep 17, 2024
Maintains: Hold
Price Target: $8 → $10
Current: $9.50
Upside: +5.26%
Viatris
Jul 19, 2024
Reinstates: Buy
Price Target: $15
Current: $9.53
Upside: +57.40%
Hims & Hers Health
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $41.34
Upside: -44.36%
Teva Pharmaceutical Industries
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $16.32
Upside: +40.93%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $28.42
Upside: +54.82%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $10.92
Upside: +55.68%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $164.98
Upside: +39.41%
Dec 15, 2023
Reiterates: Buy
Price Target: $10
Current: $0.59
Upside: +1,594.63%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $31.49
Upside: +122.29%
Feb 9, 2023
Downgrades: Hold
Price Target: $14
Current: $6.96
Upside: +101.15%
Oct 21, 2022
Initiates: Hold
Price Target: $5.5
Current: $0.58
Upside: +848.44%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $5.76
Upside: +177.78%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $3.24
Upside: +332.10%
Oct 21, 2022
Assumes: Buy
Price Target: $75
Current: $5.62
Upside: +1,234.52%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $69.45
Upside: -33.77%
Mar 28, 2022
Maintains: Buy
Price Target: $62 → $80
Current: $107.00
Upside: -25.23%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $4.39
Upside: +537.81%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $27.05
Upside: +158.78%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $10.01
Upside: +1,098.80%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.75
Upside: -27.27%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.98
Upside: +843.78%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $4.92
Upside: +631.71%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $64.48
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $620.85
Upside: -72.78%
Jan 7, 2020
Upgrades: Buy
Price Target: n/a
Current: $31.15
Upside: -
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $127.47
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $72.12
Upside: +13.70%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $185.77
Upside: +34.58%
Dec 4, 2017
Initiates: Hold
Price Target: $78
Current: $11.23
Upside: +594.57%